These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 10240261)

  • 1. Will PPIs affect your patients' attitudes?
    Patient Care; 1979 Feb; 13(3):190-1, 195-6. PubMed ID: 10240261
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescription drug products; patient labeling requirements: proposed rule.
    Fed Regist; 1979 Jul; 44(131 Pt 2):40015-41. PubMed ID: 10242793
    [No Abstract]   [Full Text] [Related]  

  • 3. Communicating with patients about their medications.
    Kessler DA
    N Engl J Med; 1991 Dec; 325(23):1650-2. PubMed ID: 1944456
    [No Abstract]   [Full Text] [Related]  

  • 4. Mandatory PPIs to begin in 1981; APhA issues strong objections.
    Small WE
    Am Pharm; 1980 Nov; NS20(11):10-1. PubMed ID: 7457342
    [No Abstract]   [Full Text] [Related]  

  • 5. Developing drug information for patients.
    Hecht A
    FDA Consum; 1977 Sep; 11(7):16-9. PubMed ID: 10304999
    [No Abstract]   [Full Text] [Related]  

  • 6. Sounding board. Creative tension: FDA and medicine.
    Kennedy D
    N Engl J Med; 1978 Apr; 298(15):846-50. PubMed ID: 345121
    [No Abstract]   [Full Text] [Related]  

  • 7. It's your health: use your medications safely.
    Correa-de-Araujo R
    J Womens Health (Larchmt); 2005; 14(1):16-8. PubMed ID: 15692273
    [No Abstract]   [Full Text] [Related]  

  • 8. Labeling regulations: 'prescribe as directed'.
    Regier H
    J Leg Med (N Y); 1974; 2(5):48-51. PubMed ID: 4548706
    [No Abstract]   [Full Text] [Related]  

  • 9. Rx with a dose of info.
    Miller RW
    FDA Consum; 1980 Nov; 14(9):22-3. PubMed ID: 10309292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A means to provide patient education: "Rx package inserts, patient package inserts, device labeling".
    Sherman M
    ONA J; 1979 Aug; 6(8):326-9. PubMed ID: 257297
    [No Abstract]   [Full Text] [Related]  

  • 11. Unapproved uses of approved drugs: The physician, the package insert, and the FDA.
    Pediatrics; 1978 Aug; 62(2):262-4. PubMed ID: 693165
    [No Abstract]   [Full Text] [Related]  

  • 12. The patient package insert--health care provider's friend or foe?
    Hirsh HL
    Nurs Homes; 1979; 28(4):24-5. PubMed ID: 10283734
    [No Abstract]   [Full Text] [Related]  

  • 13. The legal status of patient package inserts.
    Whitman JA
    Hosp Formul; 1978 Oct; 13(10):789-91. PubMed ID: 10238809
    [No Abstract]   [Full Text] [Related]  

  • 14. Patient package inserts--instructions or intrusions?
    Harvey MW
    Leg Aspects Med Pract; 1978 Aug; 6(8):47-51. PubMed ID: 703481
    [No Abstract]   [Full Text] [Related]  

  • 15. On narrowing the patient-doctor communications gap.
    FDA Consum; 1982 May; 16(4):19-21. PubMed ID: 10309635
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA's Rx for better medication information.
    Farley D
    FDA Consum; 1995 Nov; 29(9):5-10. PubMed ID: 10152787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Informing patients about drugs: a wrong way and a right way.
    Woodson DW
    Med World News; 1979 Jun; 20(13):6. PubMed ID: 10242286
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA acts on estrogen, progestin labeling.
    FDA Consum; 1977 Nov; 11(9):3. PubMed ID: 10305006
    [No Abstract]   [Full Text] [Related]  

  • 19. Educating patients about their medications: the potential and limitations of written drug information.
    Shrank WH; Avorn J
    Health Aff (Millwood); 2007; 26(3):731-40. PubMed ID: 17485751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule.
    Fed Regist; 1980 Sep; 45(179 Pt 2):60754-84. PubMed ID: 10248285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.